Life-extending prostate drug is ruled out for NHS use as officials deem it's not worth the money

Life-extending prostate drug is ruled out for NHS use as officials deem it's not worth the money A life-extending prostate cancer drug has been rejected for use on the NHS after officials ruled it is not worth the money.

The innovative drug is the first ‘precision treatment’ for the disease, which treats men based on the genetic make-up of their cancer.

It has already been approved for use in Scotland but will not be available to men in England and Wales. The Daily Mail

See also: 

• Olaparib for previously treated, hormone-relapsed metastatic prostate cancer with homologous recombination repair gene mutations [ID1640] NICE